Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jonathan E. Lipsey"'
Autor:
Shinji Tanaka, Shuqiu Zheng, Yugesh Kharel, Russell G. Fritzemeier, Tao Huang, Daniel Foster, Nabin Poudel, Eibhlin Goggins, Yusuke Yamaoka, Kinga P. Rudnicka, Jonathan E. Lipsey, Hope V. Radel, Sophia M. Ryuh, Tsuyoshi Inoue, Junlan Yao, Diane L. Rosin, Susan R. Schwab, Webster L. Santos, Kevin R. Lynch, Mark D. Okusa
Publikováno v:
Science Translational Medicine. 14
Chronic kidney disease (CKD), characterized by sustained inflammation and progressive fibrosis, is highly prevalent and can eventually progress to end-stage kidney disease. However, current treatments to slow CKD progression are limited. Sphingosine
Autor:
Jonathan E Lipsey, Larry A Allen, Laura Helmkamp, Geoffrey Harger, Stanley Swat, Tristan Dow, Dan D Matlock, Colleen K McIlvennan
Publikováno v:
Circulation. 144
Background: Despite proven benefits of guideline directed medical therapy (GDMT) for patients with heart failure with reduced ejection fraction (HFrEF), multiple studies have shown that rates of GDMT prescribing are suboptimal worldwide. The recently
Autor:
Jonathan E. Lipsey, Colleen K. McIlvennan, Laura J. Helmkamp, Geoffrey Harger, Daniel D. Matlock, Larry A. Allen
Publikováno v:
Journal of Cardiac Failure. 28:S13
Autor:
Stephen B. G. Abbott, Chikara Abe, Shuqiu Zheng, Shinji Tanaka, Ruth L. Stornetta, Junlan Yao, Nataliya I. Skrypnyk, Tsuyoshi Inoue, Jonathan E Lipsey, Patrice G. Guyenet, Mark D. Okusa, Yusuke Yamaoka, Daniel S. Stornetta, William T. Nash, Diane L. Rosin
Publikováno v:
Proc Natl Acad Sci U S A
Acute kidney injury is highly prevalent and associated with high morbidity and mortality, and there are no approved drugs for its prevention and treatment. Vagus nerve stimulation (VNS) alleviates inflammatory diseases including kidney disease; howev